Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Multicenter Clinical Control Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

NCT02639650 is registered in ClinicalTrials.gov with Weiguo Lv as lead sponsor.

NCT NCT02639650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02639650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Multicenter Clinical Control Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
Lead sponsor
Weiguo Lv
Phase
Phase 3
Overall status
Unknown status
Start date
March 1, 2016
Completion date
March 1, 2026
Enrollment
214 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational trophoblastic neoplasms